Call Us Toll Free: 1-800-388-9993
Monthly Stock Special

The $25 Special is *AbbVie Inc. (ABBV). (You must log-in as a subscriber to get this price. The non-subscirber reduced-price is $50.)

If you like discounted DRIP Enrollment, consider signing up for DRIP Club Membership. Members pay a DRIP Enrollment fee of only $30 always, Non-Members pay $60-- Click here to subscribe.

Click here to go to an order form for this company.

Here is a capsule review of our featured stock, provided by Mario Medina.

Note: To obtain the $25 fee, you must use the link on this email. you may also accept the option to print out the ONLINE Order Form and mail that in, provided you do so within the deadline.

Company Information:

Originated as a spin-off of Abbott Laboratories in 2013, AbbVie Inc. (ABBV) is a Biopharmaceutical company that discovers, develops, manufactures, and sells pharmaceutical products in the United States and international. The company is headquartered in North Chicago, Illinois. Its current total market capitalization of $169 billion makes ABBV a mega capitalization stock (a mega-cap stock has a market capitalization value of more than $100 billion) and its long history of consistent revenues and earnings growth makes it a solid company.

It is considered a well-established and diversified business with a durable competitive advantage over its rivals, which also enjoys a solid management and corporate culture. According to Yahoo! Finance, consensus estimates call for the company to earn about $10.45 per share this year, up from $8.94 per share last year, and to go to about $12.11 per share next year. AbbVie has paid dividends to investors since its creation in 2013, and has increased its payments for six consecutive years. During the past five years it has increased its dividends at an average annual rate of 19%, and its quarterly payment of $1.18 per share currently provides a yield of 4.93%.

The value of dividends reinvestment: A hypothetical investment in AbbVie has grown cumulatively (including dividends reinvested) 289.58% since its creation in 2013. The same investment has grown only 185.36% during the same period of time, excluding dividends. During the same period, a hypothetical investment in the S&P 500® index (thru the Vanguard 500 Index Admiral (VFIAX) has grown cumulatively 189.80%, including dividends reinvested. According to the data and calculations from the financial website (don’t quit your day job), a periodic monthly investment of $100 in ABBV since 2013 would has grown to $16,566, including dividends reinvested.

Its current Price to Earnings ratio (P/E --a measure of valuation) of 20.96 is 15.3% below the US Market Index (the forward P/E ratio is 9.20), its Price to Cash Flow of 9.92 is 30.7% below the index, and according to Morningstar, the stock is trading at a 1.3% discount. Technically (from the chart’s perspective) ABBV also looks attractive, trading 23.9% below its all-time high), while it is forming a long price consolidation pattern between $101 and $62 approximately, in which $62 is acting as a strong technical support level.

The actively managed mutual funds American Funds Capital Income Builder and American Funds American Mutual are major shareholders of ABBV, holding 1.28% and 0.61% of its shares respectively. The stock is also one of the 63 holdings of the mutual fund managed by Moneypaper Advisors, the MP 63 Fund (DRIPX). ABBV’s main competitors are Eli Lilly and Co. (LLY) and Merck & Co. Inc. (MRK). Its 5-year Beta (a measure of the volatility, or systematic risk in comparison to the market as a whole as evidenced by the S&P 500® Index) is 0.75, so the stock is 25% less volatile than the Market.

Best and worst years since its creation in 2013: Its best year was 2013, in which ABBV returned, including dividends, 59.3%. On the flip side, its worst year was 2015, when the stock declined 6.4%. ABBV’s dividend reinvestment plan charges no fees for cash investing, dividend reinvestment, safekeeping, automatic investment or termination of the plan. With the stock being fundamental and technically attractive, this company might be an appropriate holding for investors who wish to build a holding over the long term.

Disclosure: Mario Medina has no position in AbbVie Inc., and has no plans to initiate any position in the immediate future. However, the author is the co-manager of the MP 63 Fund (DRIPX), which does hold a position in the company. The author wrote the article himself and it expresses his own opinions. The author has no business relationship with ABBV and this article is not intended as a recommendation to invest as the information published does not take into account any subscriber's personal finances, goals or risk tolerance. Accordingly, you should be aware of all the risks associated with any financial investment and should consult an independent financial advisor for any personal investment advice. Past results illustrated in the article are for reference and educational purpose only and do not guarantee future performance.

Click here to go to an order form for this company.


Mario Medina Personal and Professional background:

Born in Cuba and graduated in Architecture from the University of Havana, Mario Medina is editor and writer of the weekly online investment newsletter El Boletín, and senior analyst for Julie Stav, Inc. Through seminars and conferences live and online, DVDs, investment e-books, articles in his blog and financial columns (on, and, videos and Podcasts, Mario teaches people inside and outside the United States. The point that differentiates Mario in his teachings, is the simplicity and softness of the language, teaching beginners, the same way he wanted to be educated when starting in the world of personal finances and investments.

Mario provides investment guidance in financial segments of Hispanic television and radio, and has had his own radio shows on those topics at Univision Radio Network, also participating in Tu Dinero, Julie Stav’s financial shows and Podcast series ( and

Analyzing the status of the market and its indexes, examining leading companies, sectors and industries, and evaluating the performance of Julie Stav’s Platinum List of Companies, his popular online Daily Market Report allows thousands of people from across the country to follow the situation of the financial world and get the essential information they need to make the best decisions about their own investments.

Today, Mario provides independent fundamental and technical analysis for the mutual fund MoneyPaper 63 (DRIPX), which is the only fund that focuses solely in companies that offer small investors Dividend Re-investment Plans. He is also a regular contributor to

Today, those who read the articles written by Mario Medina, or those who daily follow his Market Report, listen to his segments, watch his videos, or attend his seminars, could not imagine that a little over a decade ago its author knew nothing about investments or the stock market. It has been a long, arduous road for the young man newly arrived to the US with empty pockets, a suitcase full of dreams, and whose first savings came from collecting empty soda cans and recycling scrap yard. After discovering the world of finance through books and radio programs, and after years of study and sacrifice, Mario Medina now advises thousands of Hispanics on how and when to buy or sell in the stock market in order to obtain the best returns and minimize their losses.

What was the secret that allowed Mario to develop those early, small investments? "I think the key is to save and invest on a regular basis, with clearly defined long-term, diversified goals," he says. "To do so, each person must determine his o her risk tolerance level ... I do not feel comfortable risking as much as other people, and in turn many risk more than me. It is essential to know how far one can get without trying to beat the stock market every day.”

Through his regular segments, articles and analysis, Mario wants to offer everyone his successful strategies so that anyone can make the most of their work, their savings and their investments, and realize their dreams of economic prosperity. Mario Medina’s own dream is to help those interested in managing their money by knowing the risks and investing directly in the very best, teaching them the necessary steps to succeed in the stock market and other investments, participating in it directly and without brokers, so they can manage their money more efficiently and get better returns without paying more fees.

Click here to order enrollment online.